MYP_084770
Tumor necrosis factor, soluble form
Anticancer
Anticancer
▸
tumor necrosis factor family
Immunology
▸
Chemokine signaling
▸
Chemokine-like peptide
Immunology
▸
Immune modulation
▸
Cytokine modulation
Immunology
▸
Immune modulation
▸
Immunomodulatory activity
Immunology
▸
Innate immune defense
▸
Host defense peptide
▸
Host defense activity
Regulatory peptide
▸
Cell signaling / Growth factor signaling
▸
Growth factor activity
Therapeutic / Biomedical activity
▸
Enzyme replacement therapy
Standard
157 amino acids
C778H1227N215O231S2
Standard
VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL
17352.50 Da
7.00
-0.00
-0.44
-0.0000
-0.21
0.66
0.04
33.17
96.88
0.0828
21430.00
21555.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
7163.87
-71.03
246.0
236.0
565.0
1226.0
28.0
173.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0320452
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
tumor necrosis factor family
9606; 0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
69-101
Bio-Activity Profile
Cytokine
Growth factor
tumor necrosis factor family
Chemokine-like
Host defense
RECORD: Rec_0384303
VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Interleukin
32630
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anticancer
Immunomodulatory
Coagulation factor replacement
Enzyme replacement
Tasonermin has a terminal half life of 20-30 min at doses of 150 µg/m² [L1339]. This value increases as dosage increases.